Roche Holding AG (RHHBY) Friday has established the Roche Genentech Innovation Center Boston at Harvard's Enterprise Research Campus in Allston, strengthening its partnership with Harvard in disease biology, engineering, and AI/ML.
The center will serve as Roche's Cardiovascular, Renal, and Metabolism (CVRM) hub, supporting AI-driven drug discovery. With plans to employ up to 500 people, it will enhance Roche's and Genentech's R&D presence. Manu Chakravarthy will lead the site.
Roche CEO Thomas Schinecker highlighted the center's role in accelerating research by leveraging Boston's talent. Harvard President Alan Garber emphasized the collaboration's potential for medical breakthroughs. Governor Maura Healey and Mayor Michelle Wu praised the initiative for strengthening Massachusetts' position as a life sciences hub and creating high-quality jobs.
Roche, with 25,000+ employees in the U.S., has invested $11 billion over the past decade and continues expanding its pharma and diagnostics operations.
Friday RHHBY closed at $43.89 or 1.95% higher on the OTCQX.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.